Bio-rad Laboratories, Inc. Earnings

Bio-rad Laboratories, Inc.’s revenue jumped 3.85% since last year same period to $693.2Mn in the Q4 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 6.16% jump in its revenue since last 3-months.

Bio-rad Laboratories, Inc.’s net profit jumped 200.59% since last year same period to $720Mn in the Q4 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 310.59% jump in its net profits since last 3-months.

Bio-rad Laboratories, Inc.’s net profit margin jumped 196.85% since last year same period to 103.87% in the Q4 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 298.38% jump in its net profit margins since last 3-months.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.55 - a -5.9% fall from last quarter’s estimates.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.55.

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Bio-rad Laboratories, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.